Patent details

Basic Information

Publication number:

EP3154574

PCT Application Number:

US2015035375

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP158065870

PCT Publication Number:

WO2015191883

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

HOMOGENOUS ANTIBODY DRUG CONJUGATES VIA ENZYMATIC METHODS

French Title of Invention:

CONJUGUÉS ANTICORPS-MÉDICAMENT HOMOGÈNES PAR DES PROCÉDÉS ENZYMATIQUES

German Title of Invention:

HOMOGENE ANTIKÖRPER-WIRKSTOFF-KONJUGATE ÜBER ENZYMATISCHE VERFAHREN

SPC Number:

Dates

Filing date:

11/06/2015

Grant date:

11/05/2022

EP Publication Date:

19/04/2017

PCT Publication Date:

17/12/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

11/05/2022

EP B1 Publication Date:

11/05/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/06/2022

Expiration date:

11/06/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/05/2022

 

 

Name:

CSPC Megalith Biopharmaceutical Co., Ltd.

Address:

226 Huanghe Avenue, Shijiazhuang, Hebei, China (CN)

Inventor

1

Name:

HU, Sean

Address:

United States (US)

2

Name:

ALLEN, Lisha

Address:

United States (US)

Priority

Priority Number:

201462011534 P

Priority Date:

12/06/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/00; A61K 39/385; A61K 47/68;

Publication

European Patent Bulletin

Issue number:

202219

Publication date:

11/05/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages